Innoviva, Inc. (INVA)
NASDAQ: INVA · Real-Time Price · USD
23.57
+0.22 (0.94%)
At close: Jun 26, 2026, 4:00 PM EDT
23.57
0.00 (0.00%)
After-hours: Jun 26, 2026, 4:31 PM EDT
Innoviva Employees
Innoviva had 159 employees as of December 31, 2025. The number of employees increased by 32 or 25.20% compared to the previous year.
Employees
159
Change (1Y)
32
Growth (1Y)
25.20%
Revenue / Employee
$2,645,849
Profits / Employee
$3,171,975
Market Cap
1.74B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Recursion Pharmaceuticals | 600 |
| Syndax Pharmaceuticals | 298 |
| Zymeworks | 243 |
| Capricor Therapeutics | 231 |
| AnaptysBio | 104 |
| Bicara Therapeutics | 103 |
| Nanobiotix | 100 |
INVA News
- 10 days ago - Innoviva’s Nortiva Bio launches to develop long-acting oral medicines - TheFly
- 10 days ago - Nortiva Bio Launches to Develop Long-Acting Oral Medicines - Business Wire
- 12 days ago - Innoviva announces distribution, licensing agreement with Dr. Reddy’s - TheFly
- 12 days ago - Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy's for XACDURO® in Select International Markets - Business Wire
- 19 days ago - Innoviva Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 26 days ago - Innoviva to Participate in Upcoming Investor Conferences - Business Wire
- 6 weeks ago - Innoviva management to meet with BTIG - TheFly
- 6 weeks ago - Innoviva management to meet with BTIG - TheFly